Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study - Editorial comment

被引：0

作者：

Djavan, B ^{[1
]}

Fong, YK ^{[1
]}

机构：

[1] Univ Vienna, Dept Urol, Vienna, Austria

来源：

UROLOGY | 2005年 / 65卷 / 01期

关键词：

D O I：

10.1016/j.urology.2004.07.043

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：89 / 90

页数：2

共 50 条

[1] Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study
McNeill, SA
Hargreave, TB
Roehrborn, CG
UROLOGY, 2005, 65 (01) : 83 - 89
[2] Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study - Reply
McNeill, AS
UROLOGY, 2005, 65 (01) : 90 - 90
[3] Alfuzosin 10 mg once daily facilitates return to voiding in patients with acute urinary retention: Results of a placebo-controlled study
Hargreave, T
McNeill, A
Fitzsimmons, J
JOURNAL OF UROLOGY, 2003, 169 (04): : 333 - 333
[4] α-Blockers in the management of acute urinary retention: Results of a double-blind, placebo-controlled study
Kevin T. McVary
Current Urology Reports, 2005, 6 (4) : 241 - 242
[5] Safety and efficacy of alfuzosin 10mg once daily: A pooled analysis of three double-blind placebo-controlled studies
Roehrborn, CG
Van Kerrebroeck, PE
Nordling, J
JOURNAL OF UROLOGY, 2002, 167 (04): : 265 - 266
[6] Alfuzosin 10mg once daily prevents bph overall clinical progression but not acute urinary retention occurrence: Results of a 2-year placebo-controlled study
不详
EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 195 - 195
[7] Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study
Roehrborn, CG
BJU INTERNATIONAL, 2006, 97 (04) : 734 - 741
[8] Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies
Brannan, SK
Mallinckrodt, CH
Detke, MJ
Watkin, JG
Tollefson, GD
JOURNAL OF PSYCHIATRIC RESEARCH, 2005, 39 (02) : 161 - 172
[9] Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies
Roehrborn, CG
Van Kerrebroeck, P
Nordling, J
BJU INTERNATIONAL, 2003, 92 (03) : 257 - 261
[10] Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial
Bruun, Karin Due
Christensen, Robin
Amris, Kirstine
Vaegter, Henrik Bjarke
Blichfeldt-Eckhardt, Morten Rune
Bye-Moller, Lars
Holsgaard-Larsen, Anders
Toft, Palle
LANCET RHEUMATOLOGY, 2024, 6 (01): : E31 - E39

← 1 2 3 4 5 →